Research study Program year 2023 Source: CMS Open Payments

Phase 2 longterm Open Label Extension Study in UC

Research payments

$854,775

155 payments

Through program year 2023, $854,775 in research payments was reported against Phase 2 longterm Open Label Extension Study in UC, across 155 payments.

Paid by (largest first): Boehringer Ingelheim Pharmaceuticals, Inc.; Boehringer Ingelheim RCV GmbH & Co KG
ClinicalTrials.gov: No trial number was reported for this study

By program year

5 rows

Year	Kind	Amount	Payments
2023	Research	$29,543	3
2022	Research	$27,809	4
2021	Research	$72,604	6
2020	Research	$266,387	26
2019	Research	$458,431	116

Breakdown

Who paid Research payments · program years 2019–2023

Boehringer Ingelheim Pharmaceuticals, Inc. $812,680 61 payments
Boehringer Ingelheim RCV GmbH & Co KG $42,094 94 payments

Who received the money Research payments · program years 2019–2023

Texas Digestive Disease Consultants Pllc Organisation paid for research $153,079 7 payments
University of Chicago Organisation paid for research $54,158 4 payments
The Trustees Of Columbia University Organisation paid for research $52,808 2 payments
Medical Research Center Of Organisation paid for research $35,780 2 payments
Baylor College Of Medicine Allergy Organisation paid for research $35,342 1 payment
Digestive Disease Specialists INC Organisation paid for research $33,938 4 payments
Emory University Organisation paid for research $33,718 2 payments
Mcguire Research Institute Organisation paid for research $31,000 2 payments
The Trustees Of Columbia University In Organisation paid for research $29,274 1 payment
Icahn School Of Medicine Atty Mount S Organisation paid for research $28,520 2 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

8 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.